id: cirrhosis_decompensation_severity_to_maud_prescription
name: Cirrhosis Decompensation Severity â†’ MAUD Prescription Receipt
from_node:
  node_id: cirrhosis_decompensation_severity
  node_name: Cirrhosis Decompensation Severity
to_node:
  node_id: maud_prescription
  node_name: MAUD Prescription Receipt
direction: negative
category: healthcare_access
mechanism_pathway:
- 'Step 1: Patients with decompensated cirrhosis have more severe liver disease and
  complex medical needs'
- 'Step 2: Providers may perceive MAUD as lower priority compared to managing acute
  complications'
- 'Step 3: Concerns about medication interactions or contraindications in advanced
  liver disease may deter prescribing'
- 'Step 4: Patients with decompensation less likely to receive MAUD despite potentially
  greater benefit from alcohol cessation'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: A. Rabiee et al. 2023. "Medications for alcohol use disorder improve
    survival in patients with hazardous drinking and alcohol-associated cirrhosis."
    *Hepatology Communications*. https://doi.org/10.1097/HC9.0000000000000093
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:05.336860'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
_source_file: /Users/mauriceelhelou/Library/CloudStorage/OneDrive-HarvardUniversity/New
  folder (2)/healthsystems/mechanism-bank/mechanisms/healthcare_access/cirrhosis_decompensation_severity_to_maud_prescription.yaml
_category: healthcare_access
